ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | A040171 | WATSON LABORATORIES INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2002-P-0341 · 8 docket documents Lachman Consultants Services, Inc. filed this petition on behalf of a client under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA determine that an Abbreviated New Drug Application may be submitted for Oxycodone and Acetaminophen Tablets in a 2.5 mg / 300 mg | Other | 2025-02-19 | Granted | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.